ICON Chooses goBalto for Study Startup

Published on: 

Applied Clinical Trials

ICON is using Activate for all global studies, which span more than 50 countries.

goBalto announced that ICON has chosen goBalto’s flagship product Activate to  bolster ICON’s clinical study startup process on a worldwide basis. ICON is using Activate for all global studies, which span more than 50 countries. ICON has already integrated Activate with its CTMS and data warehouse, and has plans to integrate with its eTMF system.

 

Advertisement

Read the full release.